Excess β-catenin promotes accumulation of transcriptionally active p53

EMBO Journal

Volumn 18, Issue 11, 1999, Pages 3054-3063

  Damalas, Alexander ^a   Ben Ze'ev, Avri ^a   Simcha, Inbal ^a   Shtutman, Michael ^a   Martinez Leal, Juan Fernando ^a   Zhurinsky, Jacob ^a   Geiger, Benjamin ^a   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

catenin; Carcinognesis; Colorectal cancer; Mdm2; p53

Indexed keywords

BETA CATENIN; MUTANT PROTEIN; PROTEIN MDM2; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL ADHESION; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DEREGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BETA CATENIN; CELL LINE; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYSTEINE PROTEINASE INHIBITORS; CYTOSKELETAL PROTEINS; DESMOPLAKINS; GENE EXPRESSION; HUMANS; LEUPEPTINS; MICE; MUTATION; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOLUBILITY; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

ANIMALIA;

EID: 0033151867     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.11.3054     Document Type: Article

References (85)

1. Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R. (1997) β-calenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16, 3797-3804.
2. Agarwal, M.L., Taylor, W.R., Chernov, M.V., Chernova, O.B. and Stark, G.R. (1998) The p53 network. J. Biol. Chem., 273, 1-4.
3. Ahmed, Y., Hayashi, S., Levine, A. and Wieschaus, E. (1998) Regulation of armadillo by a Drosophila APC inhibits neuronal apoptosis during retinal development. Cell, 93, 1171-1182.
4. Almog, N. and Rotter, V. (1998) An insight into the life of p53: a protein coping with many functions! Biochim. Biophys. Acta Rev. Cancer, 1378, R43-R54.
5. Bedi, A., Pasricha, P.J., Akhtar, A.J., Barber, J.P., Bedi, G.C., Giardiello, F.M., Zehnbauer, B.A., Hamilton, S.R. and Jones, R.J. (1995) Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55, 1811-1816.
6. Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R. and Birchmeier, W. (1996) Functional interaction of β-catenin with the transcription factor LEF-1. Nature, 382, 638-642.
7. Behrens, J., Jerchow, B.A., Wurtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kuhl, M., Wedlich, D. and Birchmeier, W. (1998) Functional interaction of an axin homolog, conductin, with β -catenin, APC and GSK3 β. Science, 280, 596-599.
8. Ben-Ze'ev, A. and Geiger, B. (1998) Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Curr. Opin. Cell Biol., 10, 629-639.
9. Bennett, W.P. (1995) p53 alterations in progenitor lesions of the bronchus, esophagus, oral cavity and colon. Cancer Detect. Prev., 19, 503-511.
10. Bottger, A., Bottger, V., Sparks, A., Liu, W.L., Howard, S.F. and Lane, D.P. (1997) Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr. Biol., 7, 860-869.
11. Bukholm, I.K., Nesland, J.M., Karesen, R., Jacobsen, U. and Borresen, D.A. (1997) Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas. Virchows Arch., 431, 317-321.
12. Bullions, L.C. and Levine, A.J. (1998) The role of β-catenin in cell adhesion, signal transduction and cancer. Curr. Opin. Oncol., 10, 81-87.
13. Charpin, C., Garcia, S., Bouvier, C., Devictor, B., Andrac, L., Choux, R. and Lavaut, M. (1997) E-cadherin quantitative immunocytochemical assays in breast carcinomas. J. Pathol., 181, 294-300.
14. Chen, J., Marechal, V. and Levine, A.J. (1993) Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol., 13, 4107-4114.
15. Clevers, H. and van de Wetering, M. (1997) TCF/LEF factor earn their wings. Trends Genet., 13, 485-489.
16. Coste, A.L. et al. (1998) Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA, 95, 8847-8851.
17. Cox, R.T. and Peifer, M. (1998) Wingless signaling: the inconvenient complexities of life. Curr. Biol., 8, R140-R144.
18. de Stanchina, E. et al. (1998) E1A signaling to p53 involves the p19 (ARF) tumor suppressor. Genes Dev., 12, 2434-2442.
19. Donehower, L.A. et al. (1995) Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev., 9, 882-895.
20. El-Deiry, W. et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
21. Fazeli, A. et al. (1997) Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Proc. Natl Acad. Sci. USA, 94, 10199-10204.
22. Friedlander, P., Haupt, Y., Prives, C. and Oren, M. (1996) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol., 16, 4961-4971.
23. Giaccia, A.J. and Kastan, M.B. (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev., 12, 2973-2983.
24. Gumbiner, B.M. (1997) Carcinogenesis: a balance between β-catenin and APC. Curr. Biol., 7, R443-R446.
25. Hansen, R. and Oren, M. (1997) p53; from inductive signal to cellular effect. Curr. Opin. Genet. Dev., 7, 46-51.
26. Hart, M.J., de los Santos, R., Albert, I.N., Rubinfeld, B. and Polakis, P. (1998) Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 β. Curr. Biol., 8, 573-581.
27. Hart, M. et al. (1999) The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr. Biol., 9, 207-210.
28. Harvey, D.M. and Levine, A.J. (1991) p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev., 5, 2375-2385.
29. Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature, 387, 296-299.
30. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
31. Hermeking, H. and Eick, D. (1994) Mediation of c-Myc-induced apoptosis by p53. Science, 265, 2091-2093.
32. Honda, R., Tanaka, H. and Yasuda, H. (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett., 420, 25-27.
33. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S. and Kikuchi, A. (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3 β and β-catenin and promotes GSK-3 β-dependent phosphorylation of β-catenin. EMBO J., 17, 1371-1384.
34. Ilyas, M., Tomlinson, I.P., Rowan, A., Pignatelli, M. and Bodmer, W.F. (1997) β-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl Acad. Sci. USA, 94, 10330-10334.
35. Inomata, M., Ochiai, A., Akimoto, S., Kitano, S. and Hirohashi, S. (1996) Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res., 56, 2213-2217.
36. Israeli, D., Tessler, E., Haupt, Y., Elkeles, A., Wilder, S., Amson, R., Telerman, A. and Oren, M. (1997) A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J., 16, 4384-4392.
37. Johnston, L.A. and Edgar, B.A. (1998) Wingless and Notch regulate cell-cycle arrest in the developing Drosophila wing. Nature, 394, 82-84.
38. Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F. and Sherr, C.J. (1998) Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA, 95, 8292-8297.
39. Kantak, S.S. and Kramer, R.H. (1998) E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J. Biol. Chem., 273, 16953-16961.
40. Kashiwagi, H., Spigelman, A.D., Talbot, I.C., Debinski, H.S., McKie, A.B., Lemoine, N.R. and Phillips, R.K. (1997) p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis. Br. J. Surg., 84, 826-829.
41. Kemler, R. (1993) From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet., 9, 317-321.
42. Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
43. Korinek, V., Barker, N., Morin, P.J., van Wichen, D., de Weger, R., Kinzler, K.W., Vogelstein, B. and Clevers, H. (1997) Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science, 275, 1784-1787.
44. Kubbutat, M.H. and Vousden, K.H. (1998) Keeping an old friend under control: regulation of p53 stability. Mol. Med. Today, 4, 250-256.
45. Kubbutat, M.H., Jones, S.N. and Vousden, K.H. (1997) Regulation of p53 stability by Mdm2. Nature, 387, 299-303.
46. Latres, E., Chiaur, D.S. and Pagano, M. (1999) The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin. Oncogene, 18, 849-854.
47. Levi, E., Stryker, S.J. and Rao, M.S. (1996) p53 protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event? Am. J. Gastroenterol., 91, 11-14.
48. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
49. Lozano, G. and Montes de Oca Luna, R. (1998) MDM2 function. Biochim. Biophys. Acta, 1377, M55-M59.
50. McMasters, K.M., Montes de Oca Luna, R., Pena, J.R. and Lozano, G. (1996) mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts. Oncogene, 13, 1731-1736.
51. Mahmoud, N.N., Boolbol, S.K., Bilinski, R.T., Martucci, C., Chadburn, A. and Bertagnolli, M.M. (1997) Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res., 57, 5045-5050.
52. Maki, C.G., Huibregtse, J.M. and Howley, P.M. (1996) In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res., 56, 2649-2654.
53. Mitsudomi, T. et al. (1992) p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7, 171-180.
54. Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T. and Nakamura, Y. (1998) Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res., 58, 2524-2527.
55. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O. and Clevers, H. (1996) XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell, 86, 391-399.
56. Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1996) Apoptosis and APC in colorectal tumorigenesis. Proc. Natl Acad. Sci. USA, 93, 7950-7954.
57. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. and Kinzler, K.W. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science, 275, 1787-1790.
58. Muller, A.J., Young, J.C., Pendergast, A.-M., Pondel, M., Landau, N.R., Littman, D.R. and Witte, O.N. (1991) BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol., 11, 1785-1792.
59. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B. and Polakis, P. (1995) Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl Acad. Sci. USA, 92, 3046-3050.
60. Nigro, J.M., Aldape, K.D., Hess, S.M. and Tlsty, T.D. (1997) Cellular adhesion regulates p53 protein levels in primary human keratinocytes. Cancer Res., 57, 3635-3639.
61. Okamoto, K. and Beach, D. (1994) Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J., 13, 4816-4822.
62. Palombella, V.J., Rando, O.J., Goldberg, A.L. and Maniatis, T. (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell, 78, 773-785.
63. Peifer, M. (1997) β-catenin as oncogene: the smoking gun. Science, 275, 1752-1753.
64. Polakis, P. (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim. Biophys. Acta, 1332, F127-F147.
65. Pomerantz, J. et al. (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92, 713-723.
66. Prives, C. (1998) Signaling to p53: breaking the MDM2-p53 circuit. Cell, 95, 5-8.
67. Riese, J., Yu, X., Munnerlyn, A., Eresh, S., Hsu, S.C., Grosschedl, R. and Bienz, M. (1997) LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell, 88, 777-787.
68. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E. and Polakis, P. (1997) Stabilization of β-catenin by genetic defects in melanoma cell lines. Science, 275, 1790-1792.
69. Salomon, D., Sacco, P.A., Roy, S.G., Simcha, I., Johnson, K.R., Wheelock, M.J. and Ben-Ze'ev, A. (1997) Regulation of β-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. J. Cell Biol., 139, 1325-1335.
70. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. and Lowe, S.W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88, 593-602.
71. Shaulian, E., Zauberman, A., Ginsberg, D. and Oren, M. (1992) Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol., 12, 5581-5592.
72. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R. and Ben-Ze'ev, A. (1999) The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA, in press.
73. Simcha, I., Shtutman, M., Salomon, D., Zhurinsky, J., Sadot, E., Geiger, B. and Ben-Ze'ev, A. (1998) Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin. J. Cell Biol., 141, 1433-1448.
74. Sokol, S.Y. (1996) Analysis of Dishevelled signalling pathways during Xenopus development. Curr. Biol, 6, 1456-1467.
75. Sparks, A.B., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134.
76. Tetsu, O. and McCormick, F. (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
77. Tominaga, O., Hamelin, R., Trouvat, V., Salmon, R.J., Lesec, G., Thomas, G. and Remvikos, Y. (1993) Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas. Oncogene, 8, 2653-2658.
78. van de Wetering, M. et al. (1997) Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell, 88, 789-799.
79. Wagner, A.J., Kokontis, J.M. and Hay, N. (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev., 8, 2817-2830.
80. Willert, K. and Nusse, R. (1998) β-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev., 8, 95-102.
81. Williams, A.C., Browne, S.J., Yeudal, W.A., Paterson, I.C., Marshall, C.J., Lane, D.P. and Paraskeva, C. (1993) Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene, 8, 3063-3072.
82. Winston, J.T., Strack, P., Beer-Romero, P., Chu, C.Y., Elledge, S.J. and Harper, J.W. (1999) The SCF β-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev., 13, 270-283.
83. Zauberman, A., Lupo, A. and Oren, M. (1995) Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites. Oncogene, 10, 2361-2366.
84. Zhang, Y., Xiong, Y. and Yarbrough, W.G. (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92, 725-734.
85. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J. and Roussel, M.F. (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev., 12, 2424-2433.